ID: ALA1644717

Max Phase: Preclinical

Molecular Formula: C13H10BrN3O2S

Molecular Weight: 352.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)n2nc(COc3cccc(Br)c3)sc2n1

Standard InChI:  InChI=1S/C13H10BrN3O2S/c1-8-5-12(18)17-13(15-8)20-11(16-17)7-19-10-4-2-3-9(14)6-10/h2-6H,7H2,1H3

Standard InChI Key:  IRUPTZNZPHHAAH-UHFFFAOYSA-N

Associated Targets(non-human)

Xanthine dehydrogenase/oxidase 52 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Xanthine dehydrogenase 2296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 352.21Molecular Weight (Monoisotopic): 350.9677AlogP: 2.80#Rotatable Bonds: 3
Polar Surface Area: 56.49Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.26CX LogD: 3.26
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.73Np Likeness Score: -2.40

References

1. Sathisha KR, Khanum SA, Chandra JN, Ayisha F, Balaji S, Marathe GK, Gopal S, Rangappa KS..  (2011)  Synthesis and xanthine oxidase inhibitory activity of 7-methyl-2-(phenoxymethyl)-5H-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one derivatives.,  19  (1): [PMID:21163661] [10.1016/j.bmc.2010.11.034]

Source